Amylin (AMLN), Alkermes (ALKS) and Eli Lilly (LLY) Hit With Request for More Tests from FDA on BYDUREON; Shares Set to Plunge
Tweet Send to a Friend
Late Tuesday, Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
